Microfluidic fabrication of silybin nanodispersion with high dissolution rate and tunable sizes

Chemical Engineering Journal

Volumn 222, Issue , 2013, Pages 512-519

  Cui, Gai Jing ^a   Xu, Li Min ^a   Zhou, Yue ^a   Zhang, Jing Jing ^a   Wang, Jie Xin ^a   Chen, Jian Feng ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Dissolution rate; Microfluidics; Nanodispersion; Silybin

Indexed keywords

ANTI-SOLVENT PRECIPITATIONS; CHRONIC LIVER DISEASE; DISSOLUTION RATES; HIGH DISSOLUTION RATE; NANO-DISPERSIONS; SILYBIN; SIZE AND SIZE DISTRIBUTIONS; T-SHAPED MICROCHANNELS;

BIOCHEMISTRY; DISSOLUTION; DRUG PRODUCTS; FLOW RATE; MICROCHANNELS; MICROFLUIDICS; PARTICLE SIZE;

FLAVONOIDS;

EID: 84875604172     PISSN: 13858947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cej.2013.02.101     Document Type: Article

References (46)

1. Patravale V.B., Date A.A., Kulkarni R.M. Nanosuspensions: a promising drug delivery strategy. J. Pharm. Pharmacol. 2004, 56:827-840.
2. Suzanne M.D., Robert K.P. Controlling drug nanoparticle formation by rapid precipitation. Adv. Drug Deliv. Rev. 2011, 63:417-426.
3. Muller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliver. Rev. 2001, 47:3-19.
4. Merisko-Liversidge E., Liversidge G.G. Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv. Drug Deliver. Rev. 2011, 63:427-440.
5. Wu L.B., Zhang J., Watanabe W. Physical and chemical stability of drug nanoparticles. Adv. Drug Deliver. Rev. 2011, 63:456-469.
6. Wang J.X., Zhang Z.B., Le Y., Zhao H., Chen J.F. A novel strategy to produce highly stable and transparent aqueous 'nanosolutions' of water-insoluble drug molecules. Nanotechnology 2011, 22:305101.
7. Rabinow B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 2004, 3:785-796.
8. Thorat A.A., Dalvi S.V. Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspective. Chem. Eng. J. 2012, 181-182:1-34.
9. Verma S., Huey B.D., Burgess D.J. Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir 2009, 25:12481-12487.
10. Valo H.K., Laaksonen P.H., Peltonen L.J., Linder M.B., Hirvonen J.T., Laaksonen T.J. Multifunctional hydrophobin: toward functional coatings for drug nanoparticles. ACS Nano. 2010, 4:1750-1758.
11. Studart A.R., Amstad E., Gauckler L.J. Colloidal stabilization of nanoparticles in concentrated suspensions. Langmuir 2007, 23:1081-1090.
12. Margulis-Goshen K., Magdassi S. Formation of simvastatin nanoparticles from microemulsion. Nanomedicine 2009, 5:274-281.
13. Chen X.X., Lo C.Y.L., Sarkari M., Williams R.O., Johnston K.P. Ketoprofen nanoparticle gels formed by evaporative precipitation into aqueous solution. AIChE J. 2006, 52:2428-2435.
14. Lin C., Ng K.M., Wibowo C. Producing nanoparticles using precipitation with compressed antisolvent. Ind. Eng. Chem. Res. 2007, 46:3580-3589.
15. M. List, H. Sucker, Hydrosols of pharmacologically active agents and their pharmaceutical compositions comprising them, US Patent. No. 5389382.
16. Liversidge G.C., Cundy K.C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. I. Absolute oral bioavailability of nanocrystalline danazole in beagle dogs. Int. J. Pharm. 1995, 127:91-97.
17. Müller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug. Deliver. Rev. 2001, 47:3-19.
18. Sameer V.D., Rajesh N.D. Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation. Ind. Eng. Chem. Res. 2009, 48:7581-7593.
19. Matteucci M.E., Hotze M.A., Johnston K.P., Williams R.O. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir 2006, 22:8951-8959.
20. Wang J.X., Zhang Q.X., Zhou Y., Shao L., Chen J.F. Microfluidic synthesis of amorphous cefuroxime axetil nanoparticles with size-dependent and enhanced dissolution rate. Chem. Eng. J. 2010, 162:844-851.
21. Zhang S.H., Shen S.C., Chen Z., Yun J.X., Yao K.J., Chen B.B., Chen J.Z. Preparation of solid lipid nanoparticles in co-flowing microchannels. Chem. Eng. J. 2008, 144:324-328.
22. van der Woerd M., Ferree D., Pusey M. The promise of macromolecular crystallization in microfluidic chips. J. Struct. Biol. 2003, 142:180-187.
23. Nguyen N.T., Wereley S.T. Fundamentals and applications of microfluidics 2006, Artech House. Inc., MA. second ed.
24. Ali H.S.M., York P., Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int. J. Pharm. 2009, 375:107-113.
25. DeMello J., DeMello A. Microscale reactors: nanoscale products. Lab Chip. 2004, 4:11N-15N.
26. DeMello A.J. Control and detection of chemical reactions in microfluidic systems. Nature 2006, 442:394-402.
27. Karnik R., Gu F., Basto P., Cannizzaro C., Dean L., Kyei-Manu W., Langer R., Farokhzad O.C. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 2008, 8:2906-2912.
28. Sounart T.L., Safier P.A., Voigt J.A., Hoyt J., Tallant D.R., Matzke C.M., Michalske T.A. Spatially-resolved analysis of nanoparticle nucleation and growth in a microfluidic reactor. Lab chip 2007, 7:908-915.
29. Abou-Hassan A., Sandre O., Cabuil V. Microfluidics in inorganic chemistry. Angew. Chem. Int. Ed. 2010, 49:6268-6286.
30. Song Y.J., Hormes J., Kumar C.S.S.R. Microfluidic synthesis of nanomaterials. Small 2008, 4:698-711.
31. Marre S., Jensen K.F. Synthesis of nanostructures in microfluidic systems. Chem. Soc. Rev. 2010, 39:1183-1202.
32. Zhao C.X., He L.Z., Qiao S.Z., Middelberg A.P.J. Nanoparticle synthesis in microreactors. Chem. Eng. Sci. 2011, 66:1463-1479.
33. Wagner J., Kirner T., Mayer G., Albert J., Köhler J.M. Generation of metal nanoparticles in a microchannel reactor. Chem. Eng. J. 2004, 101:251-260.
34. Yun J.X., Zhang S.H., Shen S.C., Chen Z., Yao K.J., Chen J.Z. Continuous production of solid lipid nanoparticles by liquid flow-focusing and gas displacing method in microchannels. Chem. Eng. Sci. 2009, 64:4115-4122.
35. Karnik R., Gu F., Basto P., Cannizzaro C., Dean L., Kyei-Manu W., Langer R., Farokhzad O.C. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 2008, 8:2906-2912.
36. Zhao H., Wang J.X., Wang Q.A., Chen J.F., Yun J. Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in microchannel reactor. Ind. Eng. Chem. Res. 2007, 46:8229-8235.
37. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat. Nanotech. 2007, 2:469-478.
38. Staedtke V., Brähler M., Müller A., Georgieva R., Bauer S., Sternberg N., Voigt A., Lemke A., Keck C., Möschwitzer J. In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cells. Small 2010, 6:96-103.
39. Reverchon E., De Marco I., Torino E. Nanoparticles production by supercritical antisolvent precipitation: a general interpretation. J. Supercrit. Fluids. 2007, 43:126-138.
40. Johnson T.J., Ross D., Locascio L.E. Rapid microfluidic mixing. Anal. Chem. 2002, 74:45-51.
41. Jahn A., Stavis S.M., Hong J.S., Vreeland W.N., DeVoe D.L., Gaitan M. Microfluidic mixing and the formation of nanoscale lipid vesicles. ACS Nano. 2010, 4:2077-2087.
42. Zhang H.X., Wang J.X., Shao L., Chen J.F. Microfluidic fabrication of monodispersed pharmaceutical colloidal spheres of atorvastatin calcium with tunable sizes. Ind. Eng. Chem. Res. 2010, 49:4156-4161.
43. Su Y.F., Kim H., Kovenklioglu S., Lee W.Y. Continuous nanoparticle production by microfluidic-based emulsion, mixing and crystallization. J. Solid State Electrochem. 2007, 180:2625-2629.
44. Pathak P., Meziani M.J., Desai T., Sun Y.P. Nanosizing drug particles in supercritical fluid processing. J. Am. Chem. Soc. 2004, 126:10842-10843.
45. Kim M.S., Jin S.J., Kim J.S., Park H.J., Song H.S., Neubert R.H.H., Hwang S.J. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur. J. Pharm. Biopharm. 2008, 69:454-465.
46. Zhang H.X., Wang J.X., Zhang Z.B., Le Y., Shen Z.G., Chen J.F. Micronization of atorvastatin calcium by antisolvent precipitation process. Int. J. Pharm. 2009, 374:106-113.